Lensar Inc ( (LNSR) ) has released its Q4 earnings. Here is a breakdown of the information Lensar Inc presented to its investors.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
LENSAR, Inc. is a medical technology company specializing in advanced robotic laser solutions for cataract treatment, known for its ALLY Robotic Cataract Laser System™. The company recently reported a strong financial performance for the fourth quarter and full year 2024, with significant growth in revenue and system placements. LENSAR’s revenue for the fourth quarter of 2024 increased by 38% compared to the same period in 2023, driven by the successful placement of 31 ALLY systems and a 24% rise in worldwide procedure volumes. For the full year, revenue rose by 27%, reaching $53.5 million, with recurring revenue exceeding $40 million. Despite reporting a GAAP net loss due to changes in warrant liabilities, LENSAR achieved positive Adjusted EBITDA for the second consecutive quarter. Looking ahead, LENSAR anticipates continued revenue growth in 2025, supported by strong demand for its ALLY systems and recent regulatory clearances in the EU and Taiwan.